Biomind Labs Inc., a biotech research and development company, focuses on developing novel pharmaceutical drugs and nanotech delivery systems for various psychiatric and neurological conditions. The company is developing BMND01, which is in Phase II clinical trials for use in the treatment of depression; BMND08, a 5-Metoxi-N,N-dimethyltryptamine based formulation that is in Phase II clinical trials for treatment of depression and anxiety in patients with Alzheimer's-type cognitive impairment; BMND06 is in Phase I clinical trial for treatment of morbid obesity; and BMDO9 is in Phase I clinical trial for treatment of Parkinson's disease. It is also developing preclinical drug candidates, including BMND02 for the treatment of fibromyalgia, BMND03 for the treatment of addictive disorders, BMND05 for the treatment of chronic pain, BMND05 for the treatment of inflammatory disorders, and BMND07 for the treatment of major depressive disorder. The company is headquartered in Canelones, Uruguay.
常見問題
Biomind Labs 今天的股價是多少?▼
BMNDF 目前價格為 $0.25 USD,過去 24 小時下跌了 -45.61%。在圖表上更密切關注 Biomind Labs 股票的表現。
Biomind Labs 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 OTC Link 交易所,Biomind Labs 的股票以代號 BMNDF 進行交易。
Biomind Labs 的股價在上漲嗎?▼
BMNDF 股票較上週上漲 +0%,本月下跌 -45.61%,過去一年 Biomind Labs 上漲 +1,483.54%。
Biomind Labs 的市值是多少?▼
今天 Biomind Labs 的市值為 19.41M
Biomind Labs 去年的營收是多少?▼
Biomind Labs 去年的營收為 0USD。
Biomind Labs 去年的淨利是多少?▼
BMNDF 去年的淨收益為 -850,000USD。
Biomind Labs 會發放股息嗎?▼
是的,BMNDF 的股息每 年度 發放一次。每股最新股息為 0.37 。截至今日,股息殖利率(FWD)% 為 0%。
Biomind Labs 有多少名員工?▼
截至 2026年11月4日,公司共有 5 名員工。
Biomind Labs 位於哪個產業?▼
Biomind Labs從事於Health & Wellness產業。
Biomind Labs 何時完成拆股?▼
Biomind Labs 上次拆股發生於 2021年7月30日,比例為 1:32.5。
Biomind Labs 的總部在哪裡?▼
Biomind Labs 的總部位於 德國 的 Canelones。